Autoantibodies Against the Signal Peptide Domain of MUC1 in Patients With Multiple Myeloma: Implications for Disease Diagnosis and Prognosis

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2012.538
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Diagnostic and Prognostic Implications of Spine Magnetic Resonance Imaging at Diagnosis in Patients With Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

CNP Signal Peptide in Patients With Cardiovascular Disease

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2015English

Patients With Multiple Myeloma Develop SOX2-Specific Autoantibodies After Allogeneic Stem Cell Transplantation

Clinical and Developmental Immunology
2011English

Serum and Cerebrospinal Fluid Autoantibodies in Patients With Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis

PLoS ONE
Multidisciplinary
2008English

Clinical Implications of Cytogenetic Heterogeneity in Multiple Myeloma Patients With TP53 Deletion

Modern Pathology
Forensic MedicinePathology
2017English

Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis

Frontiers in Immunology
AllergyImmunology
2019English

The Importance of Serum Levels of Selected Biological Parameters in the Diagnosis, Staging and Prognosis of Multiple Myeloma

Neoplasma
Cancer Research
2010English

Flow Cytometry in the Diagnosis and Monitoring of Minimal Residual Disease in Multiple Myeloma

Oncogematologiya
OncologyHematology
2017English

Infections in Patients With Multiple Sclerosis: Implications for Disease-Modifying Therapy

Acta Neurologica Scandinavica
MedicineNeurology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy